受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | TC-S 7010 | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
||||
化学式 | C31H31ClFN7O2 |
||||||
分子量 | 588.07 | CAS No. | 1158838-45-9 | ||||
Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (170.04 mM) | ||||
Water | Insoluble | ||||||
Ethanol | Insoluble | ||||||
体内 (毎回新しく調製した物を用意してください) |
|
||||||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | TCS7010 (Aurora A Inhibitor I) is a novel, potent, and selective inhibitor of Aurora A with IC50 of 3.4 nM in a cell-free assay. It is 1000-fold more selective for Aurora A than Aurora B. Aurora A Inhibitor I (TC-S 7010) triggers apoptosis through the ROS-mediated UPR signaling pathway. |
---|---|
in vitro | Aurora A Inhibitor I is a 2,4-dianilinopyrimidine that selectively and potently inhibits Aurora A. Aurora A Inhibitor I effectively inhibits the proliferation of HCT116 and HT29 cells, with IC50 of 190 nM and 2.9 μM, respectively. The Aurora A selectivity of Aurora A Inhibitor I against Aurora B depends on a single amino acid (Thr217) of Aurora A. [1] In KCL-22 cells, Aurora A Inhibitor I (1-5 μM) increases G2/M cell fraction, induces histone H3 serine 10 phosphorylation, and suppresses mitotic Aurora A autophosphorylation on Thr288. Aurora A Inhibitor I (0.5-5 μM) also suppresses cell proliferation in KCL-22 cells, as well as BCR-ABL-negative leukemia cell lines KG-1 and HL-60. Aurora A Inhibitor I effectively induces apoptosis in KCL-22 cells at 5 μM. [2] In a recent study, Aurora A Inhibitor I is also found to inhibit cell growth of HCT116, HT29, and HeLa cells, with IC50 of 377.6 nM, 5.6 μM, and 416 nM. [3] |
特徴 | Aurora A Inhibitor I is a novel, potent, and selective inhibitor to Aurora A. |
キナーゼアッセイ | Auroras A and B Inhibition Assays | |
---|---|---|
Both Auroras A and B are assayed in ELISA format using a GST fusion (pGEX-4T) of the N-terminus of Histone H3 (aa 1−18) as substrate. Plates are coated with 2 μg/mL substrate in PBS then blocked with 1 mg/mL I-block in PBS. Kinase reactions are run for 40 min with 5 ng/mL (0.16 nM) Aurora A or 45 ng/mL (1.1 nM) Aurora B at 30 μM ATP (~ Km) in kinase buffer. Final DMSO concentration is 4%. Product is detected by incubation with antiphosphohistone H3 (Ser10) 6G3 mouse monoclonal antibody and sheep-anti-mouse HRP conjugate, followed by washing and addition of TMB substrate. After quenching with 1 M phosphoric acid, plates are read at 450 nM. | ||
細胞アッセイ | 細胞株 | HCT116 and HT29 cells |
濃度 | 0.1 nM - 10 μM, dissolved in medium lacking serum and glutamine (dissolved in DMSO as stock solution) | |
反応時間 | 72 hours | |
実験の流れ | Cells are seeded in 384-well plates on day 0 in 50 μL of complete medium and incubated overnight in a 5% CO2 atmosphere at 37 °C. On day 1, 10 μL of Aurora A Inhibitor I is added. On day 4, plates are allowed to reach room temperature, and 30 μL Cell Titer-Glo reagent is added to each well to measure total ATP levels. Plates are read after shaking 15 min at room temperature. |
|
動物実験 | 動物モデル | BALB/c nude mice bearing ARID1A isogenic tumors |
投薬量 | 30 and 60 mg/kg | |
投与方法 | IP |
Data from [J Neurosci, 2012, 32, 11050-11066]
Data from [J Neurosci, 2012, 32, 11050-11066]
, , Dr. Zhang of Tianjin Medical University
Primary Cilia Restrain PI3K-AKT Signaling to Orchestrate Human Decidualization [ Int J Mol Sci, 2022, 23(24)15573] | PubMed: 36555215 |
Phospholipase D1 promotes astrocytic differentiation through the FAK/AURKA/STAT3 signaling pathway in hippocampal neural stem/progenitor cells [ Biochim Biophys Acta Mol Cell Res, 2022, 1869(12):119361] | PubMed: 36162649 |
In vitro human cell-based aneugen molecular mechanism assay [ Environ Mol Mutagen, 2022, 63(3):151-161] | PubMed: 35426156 |
Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer [ Cancer Lett, 2021, 509:89-104] | PubMed: 33848520 |
Aurora B-dependent polarization of the cortical actomyosin network during mitotic exit [ EMBO Rep, 2021, e52387] | PubMed: 34431205 |
Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. [ Nat Commun, 2020, 11(1):1308] | PubMed: 32161261 |
MECP2 Mutations Affect Ciliogenesis: A Novel Perspective for Rett Syndrome and Related Disorders [ EMBO Mol Med, 2020, 8;e10270] | PubMed: 32383329 |
ULK1-ATG13 and Their Mitotic Phospho-Regulation by CDK1 Connect Autophagy to Cell Cycle [ PLoS Biol, 2020, 9;18(6):e3000288] | PubMed: 32516310 |
Cell division requires RNA eviction from condensing chromosomes [ J Cell Biol, 2020, 219(11)e201910148] | PubMed: 33053167 |
Bardet-Biedl Syndrome proteins regulate cilia disassembly during tissue maturation [ Cell Mol Life Sci, 2019, 76(4):757-775] | PubMed: 30446775 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。